C Malinowsky1, O Almkvist, A Kottorp, L Nygård. 1. Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden. camilla.malinowsky@ki.se
Abstract
PURPOSE: The ability to manage technology is important for performance and participation in everyday activities. This study compares the management of technology in everyday activities among people with mild-stage dementia or mild cognitive impairment (MCI) with older adults without known cognitive impairment (OA). METHOD: Persons with mild-stage dementia (n = 38), MCI (n = 33) and OA (n = 45) were observed and interviewed when managing their everyday technology at home by using the Management of Everyday Technology Assessment (META). A computer application of a Rasch measurement model was used to generate measures of participants' ability to manage technology. These measures were compared groupwise with ANCOVA. RESULTS: The management of everyday technology was significantly more challenging for the samples with mild-stage Alzheimer's disease (AD) or MCI compared to the OA sample (AD - OA, p < 0.001; d = 1.87, MCI - OA, p < 0.001; d = 0.66). The sample with MCI demonstrated a significantly higher ability to manage technology than the sample with mild-stage AD (AD - MCI, p < 0.001; d = 1.23). However, there were overlaps between the groups and decreased ability appeared in all groups. CONCLUSIONS: Persons with cognitive impairment are likely to have decreased ability to manage everyday technology. Since their decreased ability can have disabling consequences, ability to manage technology is important to consider when assessing ability to perform everyday activities.
PURPOSE: The ability to manage technology is important for performance and participation in everyday activities. This study compares the management of technology in everyday activities among people with mild-stage dementia or mild cognitive impairment (MCI) with older adults without known cognitive impairment (OA). METHOD:Persons with mild-stage dementia (n = 38), MCI (n = 33) and OA (n = 45) were observed and interviewed when managing their everyday technology at home by using the Management of Everyday Technology Assessment (META). A computer application of a Rasch measurement model was used to generate measures of participants' ability to manage technology. These measures were compared groupwise with ANCOVA. RESULTS: The management of everyday technology was significantly more challenging for the samples with mild-stage Alzheimer's disease (AD) or MCI compared to the OA sample (AD - OA, p < 0.001; d = 1.87, MCI - OA, p < 0.001; d = 0.66). The sample with MCI demonstrated a significantly higher ability to manage technology than the sample with mild-stage AD (AD - MCI, p < 0.001; d = 1.23). However, there were overlaps between the groups and decreased ability appeared in all groups. CONCLUSIONS:Persons with cognitive impairment are likely to have decreased ability to manage everyday technology. Since their decreased ability can have disabling consequences, ability to manage technology is important to consider when assessing ability to perform everyday activities.
Authors: Jared F Benge; Kara L Dinh; Erin Logue; Richard Phenis; Michelle N Dasse; Michael K Scullin Journal: Neuropsychol Rehabil Date: 2018-04-16 Impact factor: 2.868
Authors: Katherine V Wild; Nora C Mattek; Shoshana A Maxwell; Hiroko H Dodge; Holly B Jimison; Jeffrey A Kaye Journal: Alzheimers Dement Date: 2012-11 Impact factor: 21.566
Authors: Carlos Muñoz-Neira; Oscar L López; Rodrigo Riveros; Javier Núñez-Huasaf; Patricia Flores; Andrea Slachevsky Journal: Dement Geriatr Cogn Disord Date: 2012-07-11 Impact factor: 2.959
Authors: Katrin Jekel; Marinella Damian; Carina Wattmo; Lucrezia Hausner; Roger Bullock; Peter J Connelly; Bruno Dubois; Maria Eriksdotter; Michael Ewers; Elmar Graessel; Milica G Kramberger; Emma Law; Patrizia Mecocci; José L Molinuevo; Louise Nygård; Marcel Gm Olde-Rikkert; Jean-Marc Orgogozo; Florence Pasquier; Karine Peres; Eric Salmon; Sietske Am Sikkes; Tomasz Sobow; René Spiegel; Magda Tsolaki; Bengt Winblad; Lutz Frölich Journal: Alzheimers Res Ther Date: 2015-03-18 Impact factor: 6.982